Sunresin CEO Ivy Gao nominated for "Women of the Year" at CPHI Awards 2025
Sunresin CEO Ivy Gao Nominated for "Women of the Year" at CPHI Awards 2025
We are proud to announce that our CEO, Dr. Ivy Gao, has been officially nominated for the prestigious "Women of the Year" award at the CPHI Awards 2025, to be held on October 28th, 2025 in Frankfurt during the CPHI Worldwide exhibition.
This recognition honors Dr. Gao’s visionary leadership and her role in building Sunresin into a globally recognized life sciences company. Over the years, she has led the company’s transformation from a startup to a major international player in the pharmaceutical and bioprocessing industries.
“This nomination is a meaningful milestone, not only for me personally but for the entire Sunresin team,”
— Ivy Gao, CEO, Sunresin
Her entrepreneurial spirit, strong leadership, and commitment to innovation have made a lasting impact on both Sunresin and the broader life sciences industry. At CPHI, Dr. Gao will join other global leaders in celebrating progress, diversity, and the advancement of women in science and business.
We are honored to celebrate this achievement and invite all our partners to support Ivy and the Sunresin team at the gala.


Free Quote
Resources
Adsorbent Resin
Bio-Pharmaceutical & Life Science
Enzyme Carriers
Hydrometallurgy & Mining
Chelating Resin
Chemical Industry
Chromatographic Media
Wastewater Treatment&Reuse
Food & Beverage Industries
Ion Exchange Resin
Civil & Industry Water Treatment
Equipments And Projects
Plant Extraction
Catalyst Resin
Solid Phase Peptide Synthesis
Product
Application
Contact Us
Sunresin Park,No.135, jinye Road, Xi’an Hi-tech Industrial Development Zone, Shaanxi-710076, China
seplite@sunresin.com
seplite_europe@sunresin.com
+86-29-89182091
Our Product List
Latest News
01
2025 07
Sunresin Bioprocess Materials Achieve DMF Registration, Supporting Global Biopharma Compliance
Sunresin has obtained 10 Drug Master File (DMF) registrations for its chromatography resins used in antibody, vaccine, and gene therapy production. With 9 more products under review, Sunresin provides robust regulatory support for global pharmaceutical customers and accelerates IND/NDA filing efficiency with FDA and EMA compliance.
05
2025 06
Sunresin Secures Australian Patent for Lithium Adsorbent Innovation
Sunresin New Materials Co., Ltd. is pleased to announce that its invention titled “A Lithium Adsorbent and Its Preparation Method” has been officially granted a patent in Australia.
Leave a Message
Please send any questions you want to know, we will reply to you immediately.
Choose File
Submit